Celladon Corp 4
4 · Celladon Corp · Filed Mar 9, 2015
Insider Transaction Report
Form 4
Celladon CorpCLDN
ZSEBO KRISZTINA M
DirectorPresident & CEO
Transactions
- Exercise/Conversion
Common Stock
2015-03-09$1.12/sh+41,302$46,258→ 44,427 total - Sale
Common Stock
2015-03-09$24.81/sh−41,302$1,024,703→ 9,754 total - Sale
Common Stock
2015-03-09$24.71/sh−6,629$163,803→ 3,125 total - Exercise/Conversion
Stock option (right to buy)
2015-03-09−6,629→ 693,648 totalExercise: $8.00From: 2015-01-29Exp: 2024-01-28→ Common Stock (6,629 underlying) - Exercise/Conversion
Common Stock
2015-03-09$8.00/sh+6,629$53,032→ 51,056 total - Exercise/Conversion
Stock option (right to buy)
2015-03-09−41,302→ 700,277 totalExercise: $1.12From: 2013-01-27Exp: 2022-06-14→ Common Stock (41,302 underlying)
Footnotes (6)
- [F1]The amount includes shares purchased under Celladon Corporation's employee stock purchase plan prior to the reported transaction.
- [F2]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the reporting person on May 20, 2014.
- [F3]The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.13 to $25.60 per share, inclusive. The reporting person undertakes to provide to Celladon Corporation, any security holder of Celladon Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- [F4]The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.35 to $25.00 per share, inclusive. The reporting person undertakes to provide to Celladon Corporation, any security holder of Celladon Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- [F5]25% of the shares subject to the option vested and became exercisable on the one year anniversary of January 27, 2012 (the "Vesting Commencement Date"), and 1/48th of the shares vest in equal monthly installments thereafter, over the remaining three years.
- [F6]25% of the shares subject to the option vested and became exercisable on the one year anniversary of January 29, 2014 (the "Vesting Commencement Date"), and 1/48th of the shares vest in equal monthly installments thereafter, over the remaining three years.